Meeting the challenges of vascular dementia. Introduction

G Small1

  • 1UCLA NPI, Los Angeles, California, USA.

Insights

Diagnosing and managing vascular dementia (VaD) and Alzheimer's disease with cerebrovascular disease (CVD) presents challenges. Research is advancing to find treatments targeting shared pathophysiological mechanisms for improved patient outcomes.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Significant challenges exist in the diagnosis and management of vascular dementia (VaD) and Alzheimer's disease with cerebrovascular disease (CVD).
  • These challenges complicate epidemiological studies, diagnostic guidelines, and optimal treatment strategies for a substantial patient population.
  • Ongoing controversy highlights the need for clearer understanding and management approaches for these overlapping conditions.

Purpose of the Study:

  • To address the difficulties in diagnosing and managing patients with VaD or Alzheimer's disease with CVD.
  • To provide clinicians with updated information and insights into the shared pathophysiology of these conditions.
  • To explore potential therapeutic targets based on common pathophysiological mechanisms.

Main Methods:

  • An international group of physicians and researchers convened in March 2001 to discuss and resolve issues related to VaD and Alzheimer's disease with CVD.
  • The discussion focused on shared pathophysiological mechanisms, including neurotransmitter abnormalities.
  • Review of existing literature on randomized, controlled trials for agents targeting cognitive and noncognitive outcomes in these patient groups.

Main Results:

  • VaD and Alzheimer's disease appear to share common pathophysiological mechanisms beyond simple coexistence.
  • No agent has yet demonstrated broad efficacy in randomized, controlled trials for both cognitive and noncognitive outcomes in VaD and Alzheimer's disease with CVD.
  • Recent advancements in understanding pathophysiology offer promising avenues for effective treatment development.

Conclusions:

  • Treatments targeting the common pathophysiology of VaD and Alzheimer's disease with CVD hold therapeutic potential.
  • Further research into shared mechanisms is crucial for developing effective interventions.
  • Progress in understanding pathophysiology brings closer the prospect of effective treatments for Alzheimer's disease, coexisting CVD, and VaD.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...